Kelli M. Wilson

机构：National Institutes of Health, National Center for Advancing Translational Sciences · ORCID：0000-0003-2636-2766

发表论文 324 篇 · 总被引 2539 次 · h-index 26

代表论文

• An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors (2025 · ACS Pharmacology & Translational Science · 被引 3)
• Identification of potential autophagy inducers through high-throughput and high-content imaging analysis (2026 · Molecular Pharmacology · 被引 2)
• Therapeutic NAMPT inhibition reveals a targetable metabolic vulnerability in neuroblastoma (2026 · Journal of Experimental & Clinical Cancer Research)
• ENPP3 CAR T cells combined with CD206 modulation suppress adrenocortical carcinoma (2026 · Journal for ImmunoTherapy of Cancer)
• Induced pluripotent stem cell–derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities (2026 · Nature Communications)
• Supplemental Figure S4 from Inhibition of NAD<sup>+</sup>-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models (2025)